GMED vs. JNJ
Compare and contrast key facts about Globus Medical, Inc. (GMED) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GMED or JNJ.
Correlation
The correlation between GMED and JNJ is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GMED vs. JNJ - Performance Comparison
Key characteristics
GMED:
1.90
JNJ:
-0.26
GMED:
3.20
JNJ:
-0.27
GMED:
1.42
JNJ:
0.97
GMED:
1.51
JNJ:
-0.22
GMED:
13.18
JNJ:
-0.67
GMED:
4.67%
JNJ:
5.90%
GMED:
32.34%
JNJ:
15.19%
GMED:
-47.91%
JNJ:
-52.60%
GMED:
-4.47%
JNJ:
-15.65%
Fundamentals
GMED:
$11.36B
JNJ:
$352.50B
GMED:
$0.62
JNJ:
$6.06
GMED:
134.55
JNJ:
24.16
GMED:
2.19
JNJ:
0.88
GMED:
$2.48B
JNJ:
$87.70B
GMED:
$1.35B
JNJ:
$60.56B
GMED:
$517.61M
JNJ:
$29.51B
Returns By Period
In the year-to-date period, GMED achieves a 53.46% return, which is significantly higher than JNJ's -4.73% return. Over the past 10 years, GMED has outperformed JNJ with an annualized return of 12.98%, while JNJ has yielded a comparatively lower 6.11% annualized return.
GMED
53.46%
-0.06%
22.02%
57.91%
6.83%
12.98%
JNJ
-4.73%
-5.72%
0.94%
-4.56%
2.64%
6.11%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GMED vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GMED vs. JNJ - Dividend Comparison
GMED has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 3.39%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 3.39% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% | 2.83% |
Drawdowns
GMED vs. JNJ - Drawdown Comparison
The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for GMED and JNJ. For additional features, visit the drawdowns tool.
Volatility
GMED vs. JNJ - Volatility Comparison
Globus Medical, Inc. (GMED) has a higher volatility of 5.19% compared to Johnson & Johnson (JNJ) at 4.41%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GMED vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Globus Medical, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities